FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series A / Biotech startups that raised Series A in Palo Alto, United States

Biotech startups that raised Series A in Palo Alto, United States

Updated 16 Nov 2026

Reset
Biotech startups that raised Series A in Palo Alto, United States
One-time CSV
  • 34 funded companies, 33 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-a~palo-alto-california.csv34 rows × 18 columns
CompanyCityLast roundAmountDate
ImpriMedPalo AltoSeries A$10.0M2026-09-18
TwoStep TherapeuticsPalo AltoSeries A$62.5M2026-09-09
Transcripta BioPalo AltoSeries A$24.0M2026-07-22
Biostate AIPalo AltoSeries A$12.0M2025-05-20
InceptivePalo AltoSeries A$100.0M2023-09-07
GanymedePalo AltoSeries A$12.8M2022-08-09
The Public Health CompanyPalo AltoSeries A$35.0M2022-05-01
ArtificialPalo AltoSeries A$21.5M2021-05-18

8 rows of the CSV in 5 of its 18 columns.

34
Startups
$1.6B
Total raised
8
Funded in the last 12 months
$407.5M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

3 of 34
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
ImpriMed ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies. Artificial intelligence Series A $10.0M 2026-09-18 $44.7M Plug and Play, Pear VC, Draper Associates +1 51 to 100 2017
TwoStep Therapeutics TwoStep Therapeutics develops tumor-targeting therapeutics for solid tumors. Biotech Series A $62.5M 2026-09-09 $90.1M NFX, 2048 Ventures, Alexandria Venture Investments +1 11 to 50 2023
Transcripta Bio Transcripta Bio develops drugs at an accelerated pace with reduced risk. Biotech Series A $24.0M 2026-07-22 $34.4M BlueYard Capital, Jazz Venture Partners 11 to 50 2020

Table 1. Biotech startups that raised Series A in Palo Alto, United States: the 3 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 34.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 TwoStep Therapeutics TwoStep Therapeutics develops tumor-targeting therapeutics for solid tumors. Biotech Series A $62.5M 2026-09-09 $90.1M NFX, 2048 Ventures, Alexandria Venture Investments +1 11 to 50 2023
2 Transcripta Bio Transcripta Bio develops drugs at an accelerated pace with reduced risk. Biotech Series A $24.0M 2026-07-22 $34.4M BlueYard Capital, Jazz Venture Partners 11 to 50 2020
3 ImpriMed ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies. Artificial intelligence Series A $10.0M 2026-09-18 $44.7M Plug and Play, Pear VC, Draper Associates +1 51 to 100 2017

Table 2. Biotech startups that raised Series A in Palo Alto, United States: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 AME Cloud Ventures Venture capital firm Palo Alto, United States 2 6%
2 Draper Associates Venture capital firm San Mateo, United States 1 3% 1 ImpriMed
3 Murex Partners Venture capital firm Seoul, South Korea 1 3% 1 ImpriMed
4 Plug and Play Startup accelerator Sunnyvale, United States 1 3% 1 ImpriMed
5 Pear VC Venture capital firm Menlo Park, United States 1 3% 1 ImpriMed
6 NFX Startup accelerator San Francisco, United States 1 3% 1 TwoStep Therapeutics
7 2048 Ventures Venture capital firm New York, United States 1 3% 1 TwoStep Therapeutics
8 Alexandria Venture Investments Venture capital firm Pasadena, United States 1 3% 1 TwoStep Therapeutics
9 GC&H Investments Corporate venture arm San Francisco, United States 1 3% 1 TwoStep Therapeutics
10 Jazz Venture Partners Venture capital firm San Francisco, United States 1 3% 1 Transcripta Bio
11 BlueYard Capital Venture capital firm Berlin, Germany 1 3% 1 Transcripta Bio
12 Matter Venture Partners Startup accelerator Manhattan Beach, United States 1 3%
13 S32 Venture capital firm San Diego, United States 1 3%
14 Obvious Ventures Venture capital firm San Francisco, United States 1 3%
15 Andreessen Horowitz Venture capital firm Menlo Park, United States 1 3%

Table 3. Biotech startups that raised Series A in Palo Alto, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 29 85% $1.5B
Software 10 29% $184.7M
Artificial intelligence 5 15% $93.0M
Hardware 1 3% $21.5M
Fintech 1 3% $11.5M
Cybersecurity 1 3% $11.5M

Table 4. Biotech startups that raised Series A in Palo Alto, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series A 34 100% $24.0M

Table 5. Biotech startups that raised Series A in Palo Alto, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
September 2026 2 25% $72.5M
July 2026 1 12% $24.0M
June 2026 1 12% $40.0M
May 2026 2 25% $46.0M
March 2026 1 12% $25.0M
January 2026 1 12% $200.0M

Table 6. Biotech startups that raised Series A in Palo Alto, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 8 24% $407.5M
2025 2 6% $82.0M
2023 5 15% $288.5M
2022 4 12% $183.8M
2021 4 12% $224.0M
2020 2 6% $30.7M

Table 7. Biotech startups that raised Series A in Palo Alto, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 4 12%
2020 to 2022 13 38%
2015 to 2019 8 24%
2010 to 2014 5 15%
Before 2010 4 12%

Table 8. Biotech startups that raised Series A in Palo Alto, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 5 16%
11 to 50 22 69%
51 to 100 3 9%
101 to 250 2 6%

Table 9. Biotech startups that raised Series A in Palo Alto, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Palo Alto, United States whose last round is Series A are on the list?
34, in the file dated 16 November 2026. 8 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 34 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series A in Palo Alto, United States: 34 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Palo Alto

Other sectors that raised Series A in Palo Alto

Cite: FundingWatcher, 34 biotech companies in Palo Alto, United States whose most recent round is Series A, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-a/palo-alto-california/